CD8A and breast carcinoma: Here, we demonstrated a novel mechanism by which TEM not only exhibits tumor-suppressive effects on breast cancer cells but also improves CD8+ T cell-mediated anti-cancer effects through the inhibition of breast cancer-derived sEV PD-L1 levels.